Foxglove
United States
- San Francisco, CA
- 12/10/2022
- Series A
- $15,000,000
At Foxglove, we’re building powerful tools to accelerate robotics development. We believe that robotics will have a massive impact on our daily lives and the world economy over the coming decade, and that better quality software tooling will significantly accelerate this trend. Our team’s years of experience working in the robotics and self-driving industries means we are uniquely positioned to bring the advanced tools built in-house at larger companies to the increasing number of startups in this space, across a wide range of verticals.
Our first product, Foxglove Studio, is an open source visualization and diagnosis platform, specifically designed for working with robotics and sensor data. It allows you to easily inspect sensor inputs such as images, point clouds, and time series data, via a highly customizable 2D & 3D environment.
- Industry Software Development
- Website https://foxglove.dev/
- LinkedIn https://www.linkedin.com/company/foxglovedev/
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)